Clinical Trials Directory

Trials / Not Yet Recruiting

Not Yet RecruitingNCT06644794

Progesterone-modified Natural Cycle for FET

Comparison of Progesterone-modified Natural Cycle and Hormone Replacement Therapy Cycle for Endometrial Preparation in Single Frozen Blastocyst Transfer

Status
Not Yet Recruiting
Phase
Phase 3
Study type
Interventional
Enrollment
336 (estimated)
Sponsor
Shandong University of Traditional Chinese Medicine · Academic / Other
Sex
Female
Age
21 Years – 44 Years
Healthy volunteers
Not accepted

Summary

Hormone replacement therapy (HRT) cycles, despite the ease of synchronizing embryo thawing and embryo transfer timing, increase the risk of pregnancies and obstetric complications compared to natural cycles (NC). By ensuring the presence of the corpus luteum while reducing the number of monitoring sessions, the progesterone modified natural cycle (P4mNC) offers more convenience for the patient than the normal NC. This study is designed to compare the effects of P4mNC and HRT cycles on FET outcomes.

Conditions

Interventions

TypeNameDescription
DRUGProgesterone-modified natural cycle preparation for frozen embryo transferA novel endometrial preparation protocol that optimizes the natural cycle, whereby as long as the thickness of the endometrium is suitable for embryo transfer, vaginal progesterone can be used to transform the endometrium before ovulation and subsequently FET.
DRUGHormone replacement therapy cycle preparation for frozen embryo transferA traditional endometrial preparation protocol is used for FET, which involves using fixed or flexible exogenous estradiol for artificial cycles. This protocol typically involves starting exogenous estradiol on day 3 or 4 of the cycle, continuing for 7-10 days, and then discontinuing. Upon determining that the endometrial thickness meets the standard, progesterone conversion of the endometrium can be performed.

Timeline

Start date
2024-12-05
Primary completion
2026-09-10
Completion
2027-12-01
First posted
2024-10-16
Last updated
2024-10-16

Source: ClinicalTrials.gov record NCT06644794. Inclusion in this directory is not an endorsement.